Sellas Life Sciences Group Inc (SLS)

개요 뉴스 가격 이력 옵션 체인 Financials SLS 왜 하락? 토론 예측 주식 분할

Sellas Life Sciences Group Inc (SLS) 재무 분석

*모든 숫자는 백만 단위입니다.

기간 종료일	2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31
기간	3개월	3개월	3개월	3개월	3개월
Revenues	0.079	-	-	-	-
Cost Of Revenue	-	-	-	-	-
Operating Expenses	9.724	-	-	-	-
Benefits Costs and Expenses	9.645	-	-	-	-
Costs And Expenses	17.95% 9.645	8.177	9.361	9.05	11.28
Provision For Loan, Lease, And Other Losses	-	-	-	-	-
Operating Income/Loss	17.95% -9.645	-8.177	-9.361	-9.05	-11.28
Net Interest Income/Expense	92.68% 0.079	0.041	0.094	0.208	0.182
Nonoperating Income/Loss	92.68% 0.079	0.041	0.094	0.21	0.184
Income/Loss From Continuing Operations Before Tax	25.08% -9.566	-7.648	-9.361	-9.05	-11.28
Income/Loss From Continuing Operations After Tax	17.58% -9.566	-8.136	-9.267	-8.84	-11.10
Net Income/Loss	17.58% -9.566	-8.136	-9.267	-8.84	-11.10
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	4,340% 44.81	1.0092	28.36	28.35	23.55
Diluted Average Shares	4,340% 44.81	1.0092	28.36	28.35	23.55
Basic Earnings Per Share	16.00% -0.21	-0.25	-0.33	-0.31	-0.47
Diluted Earnings Per Share	16.00% -0.21	-0.25	-0.33	-0.31	-0.47
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-

INCY

$70.39

0.93%

SMMT

$18.42

1.07%

MRNA

$38.25

3.55%

UTHR

$367.36

0.83%

BGNE

$194.56

0.15%

BNTX

$108.23

5.96%